A continued look into the financial implications of initial noncompliance in community pharmacies: An unclaimed prescription audit pilot

Journal of Research in Pharmaceutical Economics

Volumn 9, Issue 2, 1998, Pages 33-57

  McCaffrey III, David J ^a   Smith, Mickey C ^b,c   Banahan III, Benjamin F ^c   Frate, Dennis A ^c,d   Gilbert, Faye W ^c  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b Dept of Management and Marketing ^*

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d Department of Anthropology

Author keywords

[No Author keywords available]

Indexed keywords

ACCOUNTING; ARTICLE; DRUG INDUSTRY; FINANCIAL MANAGEMENT; HUMAN; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0031729538     PISSN: 08966621     EISSN: None     Source Type: Journal    
DOI: 10.1300/J063v09n02_04     Document Type: Article

References (24)

1. Levy R, ed. Emerging issues in pharmaceutical cost containment. Vol. 2, No. 2. Reston, VA: National Pharmaceutical Council, 1992.
2. Luscher TF, Vetter H, Siegenthaler W, Vetter W. Compliance in hypertension: facts and concepts. J Hypertension 1985;3(Supp):3-10.
3. Olson RA, Zimmerman J, Reyes de la Rocha S. Medical adherence in pediatric populations. In: Zeiner AF, Bendell D, Walker CE, eds. Health psychology: treatment and research issues. New York: Plenum Press, 1985:113-43.
4. Fincham JE, Wertheimer AI. Elderly patient initial noncompliance: the drugs and reasons. J Geriatr Drug Ther 1988;2(4):53-62.
5. Stewart RB, Cluff LE. A review of medication errors and compliance in ambulant patients. Clin Pharmacol Ther 1972;13:463-8.
6. The forgetful patient: the high cost of improper compliance. Schering Report IX. Kenilworth, NJ: Schering Corporation, 1987.
7. Katz EF, Segal HJ. Unclaimed prescriptions. Hosp Admin Can 1971; (Nov):50+.
8. Fincham JE, Wertheimer AI. Initial drug noncompliance in the elderly. J Geriatr Drug Ther 1986;1(1):19-29.
9. Fincham JE, Wertheimer AI. Elderly patient initial noncompliance: the drugs and reasons. J Geriatr Drug Ther 1988;2(4):53-62.
10. Craghead RM, Wartski DM. Effect of automated prescription transmittal on number of unclaimed prescriptions. Am J Hosp Pharm 1989;46(Feb):310-2.
11. Craghead RM, Wartski DM. An evaluative study of unclaimed prescriptions. Hosp Pharm 1991;26:616-32.
12. Farmer KC, Gumbhir AK. Unclaimed prescriptions: an overlooked opportunity. Am Pharm 1992;NS32(10):55-9.
13. Ring PE. The unclaimed prescription phenomenon as an additional pharmacy operation burden [Thesis]. Cincinnati, OH: University of Cincinnati, 1991.
14. Kirking MH, Kirking DM. Evaluation of unclaimed prescriptions in an ambulatory care pharmacy. Hosp Pharm 1993;28:90-102.
15. Kirking MH, Zaleon CR, Kirking DM. Unclaimed prescriptions at a university hospital's ambulatory care pharmacy. Am J Health-System Pharm 1995;52:490-5.
16. McCaffrey III DJ, Smith MC, Banahan III BF, Juergens JP, Szeinbach SL. The financial implications of initial noncompliance: an investigation of unclaimed prescriptions in community pharmacies. J Res Pharm Econ 1995;6(1):39-64.
17. Lash S, Harding J. Abandoned prescriptions: a quantitative assessment of their cause. J Manage Care Pharm 1995;1(3):193-9.
18. Kamaruzaman WS. A study of unclaimed prescriptions in Hospital Universiti Sains Malaysia. Med J Malaysia 1996;50:396-400.
19. The phantom patient and community pharmacy practice. Schering Report XVIII. Kenilworth, NJ: Schering Corporation, 1996.
20. Gardner TL, Dovey SM, Tilyard MW, Gurr E. Differences between prescribed and dispensed medications. N Z Med J 1996;109:69-72.
21. Campos RM. Incumplimiento de la prescripción médica en atención primaria, en el medio rural. Attentión Primaria 1997;19(1):41-6.
22. Hamilton WR, Hopkins UK. Survey on unclaimed prescriptions in a community pharmacy. J Am Pharm Assoc 1997;NS37:341-5.
23. Skutnik S, Katsanis LP. The impact of initial noncompliance in Canadian retail pharmacies: a descriptive examination. J Pharm Market Manage 1997; 11(4): 35-54.
24. 1994 NARD-Lilly Digest. Indianapolis, IN: Eli Lilly and Co., 1994.